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IMMUNOGLOBULIN estimations at diag-
nosis have been reported in only one large
series of children with acute lympho-
blastic leukaemia (ALL) (Khalifa et al.,
1974). We therefore looked at the initial
Ig levels in a large unselected series of
children with ALL presenting to the Royal
Manchester Children's Hospital Regional
Paediatric Oncology Unit between 1971
and 1977. An attempt was made to relate
the levels to prognosis, clinical features
and response to treatment.
196 consecutive children were investiga-
ted before starting treatment. Diagnosis
of ALL was made as described by Hayhoe
et al. (1964). All samples were collected
before any blood transfusion was given,
stored at - 20°C and tested within a week.
IgG, IgA and IgM levels were measured
using immunodiffusion plates (Hoechst).
Low levels of IgA were checked using
"low level" plates. Low IgGs were re-
peated with a less diluted serum. The pre-
cision of the assays was 6.6%, 5.8% and
5*6% (coefficient of variation, n= 12)
for IgG, IgA and IgM respectively. The
age-related reference values used were
supplied by Hoechst, and are based on
several studies reported in the literature
(e.g. Allansmith et al., 1968) and standard-
ized by relating them to the normal adult
level.
Acceptedl 9 October 1979
155 children (790o) showed Ig levels
within the normal range for their age.
31 (16%) had raised levels and 10 (50)
had at least I low Ig. 4 had low IgG
(Nos. 1, 4, 8 and 9) 4 had low IgA (Nos.
2, 3, 6 and 7) 1 had both low IgG and IgA
(No. 5) and 1 had low IgA with high IgM
(No. 10). No patient had a low IgM (see
Table). None of these children with low
Igs had proteinuria, and all had normal
blood-albumin levels. The Philadelphia
chromosome was not demonstrated in any
ofthe low-immunoglobulin group.
The length of first remission was
plotted using the life-table method (Fig.)
and differences were analysed for sig-
nificance using the logrank tests of Peto
et al. (1977). There was no significant
difference between patients with normal
and raised Ig. There was, however, a
significant deleterious effect of low Ig on
remission duration (P = 0-01) which was
retained even after simultaneous adjust-
ment by the regression method of Cox
(1972) for the effects of other known prog-
nostic features (i.e. total white-cell count,
immunological surface markers, age,
mediastinal mass and degree of hepato-
splenomegaly).
Studies by Freireich et al. (1975) and
Hersh et al. (1971) at the M. D. Anderson
Hospital, Houston, U.S.A., showed that
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TABLE.-Low immunoglobulins at diagnosis in childhood lymphoblastic leukaemia
Age
Patient Sex (years)
I M 8
WBCI
(109/1)
12-5
2 M 71 15-8
3 F 11 11-8
4 M 4 182-0
5 F 4 38-3
6 M 61 4-4
7 M 7 7-0
8 F 4 15-9
9 M 31 19-3
10 M 6 87-0
Immunoglobulins
mg/100 ml*
IgG IgA IgM
280 60 100
(40) (100)
824
895
445
(74)
335
(56)
930
840
500
(83)
485
(80)
1500
35
(57)
44
(60)
50
27
(73)
38
(72)
32
(67)
CR
timet
(days)
24
First
remis-
sion
(mt
C
114 143
77 22
Second
remis-
sion
Sur-
vival
hs) (mths) (days) Comments
)9+ - 100+ Salmonella septi-
caemia and pro-
longed carrier.
9 1 16 Difficult inductions
7 3 13
90 55 11 nil 12 Difficult first-
remission induction
210 nil nil (48 h) Died with intra-
cranial haemorrhage
65 29 19 nil 24+ Non-B non-T cell
50 nil nil 6 B cell
72 89 28 26 2 29 Non-B non-T cell
48 50 27 23 nil 26+ Non-B non-T cell
35
(66)
194 23 5 7 19
$ At presentation.
t Time from diagnostic marrow to complete remission marrow.
* Bracketed numbers below the relevant Ig level are the percentages of the lower limit of normal.
Only Patient 1 had undue susceptibility to infection, and he is also the only one who has done well. All
other patients had strong resistance to chemotherapy, despite other good-risk features in Patients 2, 3, 6, 8
and 9.
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FIG.-Length of first remission in children
with ALL, according to Ig levels. The
"Low" group, with one or more low Ig
results, did significantly worse (P =0-01)
than the other patients. There is no differ-
ence between patients with high and normal
Ig levels.
cellular immunity of patients with acute
leukaemia at diagnosis, and after induc-
tion ofremission, was related to the subse-
quent response to treatment. The delayed-
hypersensitivity skin test with dermato-
phyton was the single characteristic sig-
nificantly related to response. Khalifa
et al. (1974) studied 120 children with
acute leukaemia and demonstrated that
those with low IgG at diagnosis had a
poor prognosis. We have confirmed this,
and also shown that a low IgA may fore-
cast a poor result. Length offirst remission
was chosen as the main prognostic indica-
tor because of the known very poor sur-
vival afterrelapse ofchildhood ALL shown
by Cornbleet & Chessells (1978).
Membrane surface markers were not
available when 6 ofour patients presented.
Of the other 4, 1 had a B-cell leukaemia,
and the other 3 were of the non-B, non-T
type. Three patients had an initial white-
cell count over 20 x 109/1, a feature which
may be associated with leukaemia of T-
cell origin, but no patient had an anterior
mediastinal mass. The group is too small
for comment on susceptibility to infection,
which might be expected to be enhanced,
but the one patient who has otherwise
done well (Patient 1) had an episode of
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salmonella septicaemia with subsequent
prolonged faecal excretion.
The outstanding feature was the very
poorresponse totreatment, forboth induc-
tion of remission and re-induction after
relapse. Only 1 case (with low initial IgG)
responded well. The median lengths of
first remission (8 months) and of survival
(17k months) are also poor. Only 3 of the
10 patients are still alive. All but Patient
1 have relapsed, although 5 had what are
considered better risk features (i.e. lack of
mediastinal mass, initial white-cell count
less than 20 x 109/1 and age below 12
years). Two patients (Nos. 2 and 4) needed
prolonged treatment before a first remis-
sion was induced. Second remissions in 9
of the children were very difficult to
achieve. The patient with B-cell leukaemia
did not achieve a remission, a feature
which has been well described in this type
of disease by Freireich et al. (1975) and
others.
Recent reports from Broder et al.
(1977, 1978) have shownthatsomepatients
with leukaemia of T-cell origin have
hypogammaglobulinaemia because the
blast cells have suppressor-cell activity.
Helper cells have been described in some
of Broder's patients with Sezary's syn-
drome, and both helper and suppressor
cells in a T-cell-derived chronic lympho-
cytic leukaemia patient of Saxon et al.
(1979). Such findings indicate that neo-
plastic cells can retain normal function,
and may thus provide a valuable supply
of human helper and suppressor cells for
research. Their characterization may also
define patients with acute leukaemia who
have exceptionally poor anti-tumour and
anti-microbial defences. It would also
appear that patients with B-cell and non-
B-, non-T (common) ALL may also have a
low Ig level which is related to a particu-
larly poor prognosis, and outweighs other
factors which would otherwise indicate a
good risk. Consequently, identification of
patients with low IgA or IgG will allow
more accurate stratification of trials for
analysis and make possible the selection
of these patients for non-conventional
intensive treatments such as marrow
transplantation.
We are grateful to Mr Trevor Carr for surface
marker tests and to Miss E. M. Hammond for
immunoglobulin estimations.
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